(Q37783285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795765%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795765%20AND%20SRC:MED&resulttype=core&format=json

14-alpha sterol demethylase

12 February 2020

main subject

Aspergillus fumigatus

0 references

1 reference

6 February 2019

1 reference

antifungal drug resistance

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795765%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Maiken C Arendrup

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795765%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Susan Julie Howard

series ordinal

1

1 reference

23 August 2017

Maiken Cavling Arendrup

series ordinal

2

1 reference

23 August 2017

publication date

26 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795765%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795765%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

49 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795765%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

S90-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20795765%20AND%20SRC:MED&resulttype=core&format=json

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Azole-resistance in Aspergillus: proposed nomenclature and breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Changes in susceptibility to posaconazole in clinical isolates of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Efflux-mediated antifungal drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Disruption of the Aspergillus fumigatus ECM33 homologue results in rapid conidial germination, antifungal resistance and hypervirulence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Resistance to echinocandin-class antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Emergence of Candida tropicalis resistant to caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Acquired resistance to echinocandins in Candida albicans: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Rapid, high-throughput, multiplex, real-time PCR for identification of mutations in the cyp51A gene of Aspergillus fumigatus that confer resistance to itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Rapid detection of triazole antifungal resistance in Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

Detection of Aspergillus fumigatus and a mutation that confers reduced susceptibility to itraconazole and posaconazole by real-time PCR and pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469

The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.508469